Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 9.66% vs 44.95% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 60.87% vs 28.88% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -20.75% vs 19.71% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -45.70% vs 78.85% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Ningbo Menovo Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 9.66% vs 44.95% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 28.81% vs -1.47% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 60.87% vs 28.88% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 3.44% vs 82.35% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -20.75% vs 19.71% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -24.30% vs 31.65% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -45.70% vs 78.85% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 90.57% vs -23.19% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






